Clinical trial
Tack Optimized Drug Coated Balloon Angioplasty in the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System™
NCT02802306 is registered in ClinicalTrials.gov with Philips Clinical & Medical Affairs Global as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tack Optimized Drug Coated Balloon Angioplasty in the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System™
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- May 31, 2020
- Enrollment
- 201 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.